STOCK TITAN

ORCHID VENTURES INC - ORVRF STOCK NEWS

Welcome to our dedicated page for ORCHID VENTURES news (Ticker: ORVRF), a resource for investors and traders seeking the latest updates and insights on ORCHID VENTURES stock.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect ORCHID VENTURES's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of ORCHID VENTURES's position in the market.

Rhea-AI Summary

Orchid Ventures (CSE:ORCD, OTC PINK:ORVRF) entered an exclusive agreement with Eurox Pharma GmbH for the submission of a vaporizer device for Medical Device Approval in Germany. Collaborating with Eurox and their OEM supplier, PurTec, the companies will conduct safety studies to validate the device's efficacy. Once approved, Eurox will have exclusive rights to sell and distribute the product in the EU, UK, and Brazil. This partnership marks PurTec's first international project, enhancing Orchid's market position in the competitive European medical cannabis landscape.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
partnership
-
News
Rhea-AI Summary

Orchid Ventures held its annual general meeting (AGM) on December 10, 2021, with 9.83% of shareholders present. All proposed items were approved by shareholders, including the receipt of annual audited financial statements for 2020 and 2021, the election of four directors, and the appointment of DMCL LLP as auditors. The Company focuses on innovative cannabis products and owns PurTec Delivery Systems, known for high-quality vaporizer hardware. Orchid aims to drive revenue growth through strong branding and strategic partnerships.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
Rhea-AI Summary

Orchid Ventures reported its financial results for Q1 2022, ending September 30, 2021, showing revenues of $398,423, down $1,555,568 from the same quarter in 2020. The company incurred a net loss of $221,201 compared to a profit of $97,276 last year. Despite an increase in marketing expenses by 2700% to support brand awareness, operational expenses decreased to $678,081. Management anticipates improvements in revenue generation due to recent marketing initiatives and a focus on building a sales pipeline for future growth.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
Rhea-AI Summary

Orchid Ventures has reported its audited annual financial results for the year ending June 30, 2021. Revenues increased by 137% to $3,720,366, with a gross profit of $1,198,662, marking a substantial recovery from a gross loss of $152,466 in the previous period. Net losses decreased by 55% to $3,150,866. The company has implemented a strategic shift away from cannabis cultivation towards licensing and hardware delivery systems. Total assets rose to $2,182,197. The operational expenses were reduced by 27% to $3,951,165.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
-
Rhea-AI Summary

Orchid Ventures, Inc. (CSE:ORCD, OTC PINK:ORVRF) has announced a delay in filing its annual financial statements for the year ended June 30, 2021, missing the October 28, 2021 deadline. The delay, attributed to the nature of the company's business and the impact of the COVID-19 pandemic, has led to a management cease trade order (MCTO) against its CEO and CFO. The company aims to file by December 27, 2021, with expectations to complete the filing by November 5, 2021. They will provide bi-weekly updates during this period.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
Rhea-AI Summary

Eybna, a leading terpene manufacturer, has partnered with renowned cannabis brands Spherex and Orchid Essentials to develop custom terpene formulations tailored to enhance consumer experiences. This collaboration aims to ensure consistency across products as these brands expand into new markets. Eybna's CEO highlighted the importance of data-driven formulations that reflect unique genetics and aromas. Both Spherex and Orchid Essentials are well-established in the cannabis sector, with innovative offerings and plans for growth in multiple states.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.85%
Tags
partnership
Rhea-AI Summary

Orchid Ventures (CSE:ORCD, OTC:ORVRF) reported a significant sales milestone, achieving over $545,000 in closed sales for August 2021 within just 18 days, the highest since October 2020. Sales primarily stemmed from PurTec Delivery Systems products in California, Florida, and Oregon. The launch in California with licensee Gold Flora has been successful, with a focus on expanding accounts and product offerings. Orchid's PurGuard software aims to limit underage cannabis use, while new marketing campaigns are set to enhance visibility.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
17.72%
Tags
none
-
Rhea-AI Summary

On August 17, 2021, Orchid Ventures announced the launch of its innovative PurGuard technology platform aimed at preventing vape product usage by minors. This system requires age verification through a mobile app and includes an auto-lock feature for enhanced safety. Orchid's CEO, Corey Mangold, emphasized its significance for consumer safety in the cannabis industry. The PurGuard products will allow users to access detailed product information and are expected to set a new industry standard for safety. These products will be showcased at MJ Biz Con in October 2021.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.39%
Tags
none
-
Rhea-AI Summary

Orchid Ventures (CSE:ORCD, OTC PINK:ORVRF) announced that CEO Corey Mangold will present at the Summer Emerge Conference on June 24, 2021. The presentation, titled "Vaping & Federal Legislation", will focus on the implications of federal cannabis legalization on consumer safety and product testing. It will also discuss Pre-Market Tobacco Applications and safety concerns related to vaping. Attendees can register for the virtual event and use code SPKRPALS for a 25% discount.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.5%
Tags
conferences
Rhea-AI Summary

Orchid Ventures (CSE:ORCD OTC:ORVRF) announces a 1-for-4 share consolidation effective March 31, 2021, to enhance its capital structure. Following this, the company closed a private placement of 16,838,000 units at $0.25 each, raising $4.2 million. Each unit includes one post-consolidation share and half a warrant, exercisable at $0.40. The funds aim to support working capital and aggressive marketing of its PurTec vaporizer products. The company plans a virtual shareholder update in the coming month.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none

FAQ

What is the market cap of ORCHID VENTURES (ORVRF)?

The market cap of ORCHID VENTURES (ORVRF) is approximately 52.0.

ORCHID VENTURES INC

OTC:ORVRF

ORVRF Rankings

ORVRF Stock Data

52
41.48M
8.35%
Drug Manufacturers - Specialty & Generic
Healthcare
Link
United States of America
Ladera Ranch